Abstract:<p>An antibody's stability greatly influences its performance (i.e. its specificity and affinity). Thus, stability is a major issue for researchers and manufacturers, especially with the increasing use of antibodies in therapeutics, diagnostics and rapid analytical platforms. Here we review antibody stability under five headings: (i) measurement techniques; (ii) stability issues in expression and production (expression, proteolysis, aggregation); (iii) effects of antibody format and engineering on stability and (iv) formulation, drying and storage conditions. We consider more than 100 sources, including patents, and conclude with (v) recommendations to promote antibody stability.</p>
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the significant impact of antibody stability on antibody performance (i.e., its specificity and affinity). Specifically, the article emphasizes the importance of antibody stability in the following aspects:
1. **Stability issues in expression and production**: including problems such as expression, proteolysis, and aggregation, which can affect the antibody yield and product quality.
2. **The impact of antibody format and engineering on stability**: Antibodies of different formats (such as monoclonal antibodies, antibody fragments, etc.) and antibodies modified by genetic engineering have differences in stability and application effects.
3. **Formulation, drying, and storage conditions**: These factors are crucial for the long - term stability and function maintenance of antibodies.
With the wide application of antibodies in treatment, diagnosis, and rapid analysis platforms, ensuring antibody stability has become a key challenge for researchers and manufacturers. Through a review of more than 100 literatures (including patents), this paper explores how to measure, analyze, and improve antibody stability and puts forward suggestions for promoting antibody stability.
### Summary of Key Issues
- **Stability issues in expression and production**:
- **Proteolysis/Fragmentation**: Antibodies may be degraded by proteases in host cells during the expression process, resulting in a decrease in yield and damage to product quality.
- **Aggregation**: Antibodies are prone to aggregation, which not only affects their structure and function but may also lead to an increase in immunogenic reactions.
- **The impact of antibody format and engineering on stability**:
- Antibodies of different formats (such as single - chain variable region fragment scFv, Fab fragment, etc.) are different in stability and application effects.
- Genetic engineering modification (such as CDR grafting, introduction of disulfide bonds, etc.) can improve the stability of antibodies.
- **Formulation, drying, and storage conditions**:
- Appropriate formulation components (such as excipients), storage temperature, and drying treatment methods can significantly affect the long - term stability of antibodies.
### Conclusions and Recommendations
Finally, the paper puts forward a number of suggestions aimed at promoting antibody stability, including optimizing the expression system, improving the purification process, selecting appropriate formulation components, and controlling storage conditions. Through these measures, the yield, quality, and long - term stability of antibodies can be improved, so that they can be better applied in the fields of treatment and diagnosis.
### Formula Examples
- **Melting point temperature \(T_m\)**: Represents the temperature at which 50% of the protein is unfolded and can be measured by differential scanning calorimetry (DSC).
\[
T_m=\text{Temperature at which 50\% of the protein is unfolded}
\]
- **IC50**: Represents the ligand concentration required to inhibit 50% of the binding and is usually used to evaluate the affinity of antibodies.
\[
IC_{50}=\text{Ligand concentration leading to 50\% inhibition of binding}
\]
These formulas and concepts help readers to understand more deeply the methods for measuring and evaluating antibody stability.